New York [US], May 17 (ANI): A unique commission that issued major new recommendations aimed at fully understanding and reducing the global burden of heart disease in women was led by Roxana Mehran, MD, Professor of Medicine, and Population Health Science and Policy, and Director of Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai.
May 17, 2021
A de-escalation antiplatelet strategy of switching from the more-potent ticagrelor (Brilinta; AstraZeneca) to clopidogrel at 1 month after PCI for acute MI is superior to continuing on ticagrelor and aspirin in terms of net clinical benefit, according to the TALOS-AMI trial.
“This study was conducted only in South Korea. However, although the prevalence of the CYP2C19 loss-of-function allele is significantly higher in Koreans than in other ethnic groups, this study showed the clinical safety of switching in this population, suggesting the potential of applying this de-escalation strategy to other ethnic groups,” said Kiyuk Chang, MD, PhD (The Catholic University of Korea, Seoul, Republic of Korea), who presented the findings in a late-breaking clinical trial session yesterday at the American College of Cardiology 2021 Scientific Session.
May 17, 2021
Group’s worldwide health recommendations aim to improve outcomes by 2030
(New York, NY – May 16, 2021) – A unique commission that today issued major new recommendations aimed at fully understanding and reducing the global burden of heart disease in women was led by Roxana Mehran, MD,
Professor of Medicine, and Population Health Science and Policy, and Director of Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai.
“The Lancet Women and Cardiovascular Disease Commission” developed specific, worldwide recommendations for heart disease prevention and treatment based on an unprecedented global review and analysis. The recommendations included expanding education and health programs, and research on women’s heart disease. The commission’s report was published on May 16 in
CBS News CBS News May 17, 2021, 11:01 AM
Heart disease is the leading cause of death for women. Researchers fear our health system isn t keeping up.
Heart disease is the leading cause of death for women globally.
The report made a number of recommendations, including more education on early detection for health care providers and patients, recruiting more women for cardiac studies and prioritizing research on heart disease in women.
Doctors say strengthening the health care system s ability to detect these cardiovascular issues and building awareness of them could prevent numerous deaths and near-fatal incidents like that of New York resident Yulia Nurikyan, who knew something was not right just weeks before her baby was due.